Strategic Initiative

Slingshot members are tracking this corporate initiative:

Ipsen (IPSEY) Agrees to Acquire Some of Merrimack's (MACK) Oncology Assets, Including Pancreatic Cancer Drug Onivyde, For Up to $1 Billion

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MACK

100%
IPSEY

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Jan 09, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Oncology Assets, Pancreatic Cancer, Onivyde